ClinicalTrialsFinder

High-risk Locally Advanced Clinical Trials in Guangzhou

1 recruitingGuangzhou, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial)

Rectal AdenocarcinomaHigh-risk Locally AdvancedShort-course Radiotherapy (SCRT)+2 more
Sixth Affiliated Hospital, Sun Yat-sen University76 enrolled1 locationNCT07669220